Limits...
Occult axillary lymph node metastases are of no prognostic significance in breast cancer.

Millis RR, Springall R, Lee AH, Ryder K, Rytina ER, Fentiman IS - Br. J. Cancer (2002)

Bottom Line: The median follow-up was 18.9 years with 153 breast cancer related deaths.Multivariate analysis, however, showed that survival was related to tumour size and histological grade.This node-negative group was compared with a second group of 202 patients who had one involved axillary node found on initial assessment of the haematoxylin and eosin sections; survival was worse in the patients in whom a nodal metastasis was found at the time of surgery.

View Article: PubMed Central - PubMed

Affiliation: Hedley Atkins ICRF Breast Pathology Laboratory, Guy's Hospital, London SE1 9RT, UK.

Show MeSH

Related in: MedlinePlus

Overall survival of axillary node negative patients with and without occult metastases, and of patients with a single involved axillary node. There was no difference between node negative patients with and without occult metastases χ2=1.9, P=0.17. Survival was worse in patients with a single involved axillary node compared with the node negative group χ2=32.7, P<0.0001, and compared with the node negative patients with occult metastases χ2=4.1, P=0.04. The table underneath shows patients at risk at 5-yearly intervals.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2375207&req=5

fig1: Overall survival of axillary node negative patients with and without occult metastases, and of patients with a single involved axillary node. There was no difference between node negative patients with and without occult metastases χ2=1.9, P=0.17. Survival was worse in patients with a single involved axillary node compared with the node negative group χ2=32.7, P<0.0001, and compared with the node negative patients with occult metastases χ2=4.1, P=0.04. The table underneath shows patients at risk at 5-yearly intervals.

Mentions: Overall survival (Figure 1Figure 1


Occult axillary lymph node metastases are of no prognostic significance in breast cancer.

Millis RR, Springall R, Lee AH, Ryder K, Rytina ER, Fentiman IS - Br. J. Cancer (2002)

Overall survival of axillary node negative patients with and without occult metastases, and of patients with a single involved axillary node. There was no difference between node negative patients with and without occult metastases χ2=1.9, P=0.17. Survival was worse in patients with a single involved axillary node compared with the node negative group χ2=32.7, P<0.0001, and compared with the node negative patients with occult metastases χ2=4.1, P=0.04. The table underneath shows patients at risk at 5-yearly intervals.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2375207&req=5

fig1: Overall survival of axillary node negative patients with and without occult metastases, and of patients with a single involved axillary node. There was no difference between node negative patients with and without occult metastases χ2=1.9, P=0.17. Survival was worse in patients with a single involved axillary node compared with the node negative group χ2=32.7, P<0.0001, and compared with the node negative patients with occult metastases χ2=4.1, P=0.04. The table underneath shows patients at risk at 5-yearly intervals.
Mentions: Overall survival (Figure 1Figure 1

Bottom Line: The median follow-up was 18.9 years with 153 breast cancer related deaths.Multivariate analysis, however, showed that survival was related to tumour size and histological grade.This node-negative group was compared with a second group of 202 patients who had one involved axillary node found on initial assessment of the haematoxylin and eosin sections; survival was worse in the patients in whom a nodal metastasis was found at the time of surgery.

View Article: PubMed Central - PubMed

Affiliation: Hedley Atkins ICRF Breast Pathology Laboratory, Guy's Hospital, London SE1 9RT, UK.

Show MeSH
Related in: MedlinePlus